title: Update of the recommendations on biosimilar low-molecular-weight heparins from the Scientific Subcommittee on Control of Anticoagulation of the International Society on Thrombosis and Haemostasis.
authors.affiliation: Clinical Pharmacology, Medical Faculty Mannheim, University of Heidelberg, Maybachstrasse 14, Heidelberg, Germany. job.harenberg@medma.uni-heidelberg.de
authors.forename: J
authors.initials: J
authors.lastname: Harenberg
authors.forename: J
authors.initials: J
authors.lastname: Walenga
authors.forename: G
authors.initials: G
authors.lastname: Torri
authors.forename: O E
authors.initials: OE
authors.lastname: Dahl
authors.forename: L
authors.initials: L
authors.lastname: Drouet
authors.forename: J
authors.initials: J
authors.lastname: Fareed
mesh_terms: D000818:Animals; D000925:Anticoagulants / Q000592:standards* / Q000627:therapeutic use*; D059451:Biosimilar Pharmaceuticals / Q000592:standards* / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects*; D032921:Consensus; D006495:Heparin, Low-Molecular-Weight / Q000592:standards* / Q000627:therapeutic use*; D006801:Humans; D011786:Quality Control
chemical_list: D000925:Anticoagulants; D059451:Biosimilar Pharmaceuticals; D006495:Heparin, Low-Molecular-Weight